Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 12 - 27 crawled time : 12:30 save search
Supply Chain Control Tower Market Size to Reach USD 11.54 Billion in 2028 | Rising Demand for Autonomous Decision-Making Tools is a Key Factor Driving Industry Revenue Growth, says Emergen Research
Published: 2021-12-27 (Crawled : 12:30) - prnewswire.com
SAPGF | News | $176.433 1.9K
|
Technology Services
|
| O: -1.68%
H: 4.33%
C: 3.37%
SAP | News | $188.42 0.22% 180K
|
Technology Services
|
| O: -0.16%
H: 1.07%
C: 1.03%
IBM | $183.34 0.63% 880K
|
Technology Services
|
| O: 0.0%
H: 0.78%
C: 0.76%
autonomous ema control research growth merge
Movano Unveils Smart Ring Designed for Women Seeking More Approachable Health Insights
Published: 2021-12-27 (Crawled : 12:30) - prnewswire.com
MOVE | $0.4841 940
|
Manufacturing
|
| O: -2.68%
H: 4.13%
C: -0.34%
health women designation
DEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of Meta Platforms, Inc. f.k.a. Facebook, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 27, 2021 - FB
Published: 2021-12-27 (Crawled : 12:30) - prnewswire.com
FB S | $196.64 0.51%
|
Technology Services
|
| O: 1.08%
H: 2.66%
C: 2.16%
oda deadline platform
IRIDIUM TO PARTICIPATE AT THE 24TH ANNUAL NEEDHAM VIRTUAL GROWTH CONFERENCE
Published: 2021-12-27 (Crawled : 12:30) - prnewswire.com
IRDM | News | $28.92 0.63% 170K
|
Communications
|
| O: -0.57%
H: 0.07%
C: -0.62%
conference annual needham growth
Dogness Smart Discover GPS Pet Tracker Reaches 2nd Most Popular Pet Tracker in China After Only 3 Weeks
Published: 2021-12-27 (Crawled : 12:30) - prnewswire.com
BQ | $0.2521 -0.36% 31K
|
Consumer Non-Durables
|
| O: 2.17%
H: 7.45%
C: 4.26%
DOGZ | $6.37 2.2K
|
Consumer Non-Durables
|
| O: 0.65%
H: 1.92%
C: -3.38%
COST | $719.65 -0.42% 180K
|
Retail Trade
|
| O: 0.21%
H: 2.57%
C: 2.16%
china
AZZ Inc. to Review Third Quarter Fiscal Year 2022 Financial Results on Monday, January 10, 2022
Published: 2021-12-27 (Crawled : 12:30) - prnewswire.com
AZZ | News | $83.41 0.58% 22K
|
Producer Manufacturing
|
| O: -0.17%
H: 1.59%
C: 1.4%
financial results results
Talos Energy Releases 2021 ESG report
Published: 2021-12-27 (Crawled : 12:30) - prnewswire.com
TALO | $13.72 -0.22% 100K
|
Energy Minerals
|
| O: -0.71%
H: 5.85%
C: 5.74%
esg energy
BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
Published: 2021-12-27 (Crawled : 12:30) - biospace.com/
TECH | $63.19 -0.78% 100K
|
Health Technology
|
| O: 0.27%
H: 0.94%
C: 0.94%
FDA Authorizes Further NurOwn® Dosing Under Expanded Access Program
Published: 2021-12-27 (Crawled : 12:30) - biospace.com/
BCLI A | $0.535 1.91% 76K
|
Health Technology
|
| O: 3.49%
H: 2.08%
C: -3.12%
nurown fda program
Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19
Published: 2021-12-27 (Crawled : 12:30) - globenewswire.com
PSTI | $1.0 -2.91% 8.0%
|
Health Technology
|
| O: -7.73%
H: 0.0%
C: -10.06%
covid-19 respiratory covid topline results results topline syndros
Aterian Signs A $50 Million Credit Facility With MidCap Financial Trust
Published: 2021-12-27 (Crawled : 12:30) - globenewswire.com
ATER | News | $2.29 4.09% 4.2K
|
Manufacturing
|
| O: -2.43%
H: 1.36%
C: -4.75%
APO | $114.12 0.31% 130K
|
Finance
|
| O: 0.39%
H: 0.47%
C: -0.72%
trust
Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference
Published: 2021-12-27 (Crawled : 12:30) - globenewswire.com
ACRS | $1.22 94K
|
Health Technology
|
| O: -0.78%
H: 0.91%
C: -0.13%
conference therapeutics
BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study
Published: 2021-12-27 (Crawled : 12:30) - biospace.com/
BBIO | $25.405 -0.22% 86K
|
Health Technology
|
| O: -68.88%
H: 4.03%
C: -9.97%
topline results results topline phase 3 pharma
Microbot Medical Announces Strategic Collaboration with Stryker Corporation to Develop the LIBERTY® Robotic System for Neurovascular Applications
Published: 2021-12-27 (Crawled : 12:30) - globenewswire.com
SYK | $340.075 1.54% 370K
|
Health Technology
|
| O: 0.41%
H: 0.47%
C: 0.4%
MBOT | $0.8799 42K
|
Health Technology
|
| O: 71.4%
H: 3.34%
C: -3.66%
liberty application system collaboration
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Patients With Unresectable, Advanced or Recurrent Endometrial Carcinoma That Progressed After Cancer Chemotherapy
Published: 2021-12-27 (Crawled : 12:30) - biospace.com/
MRK | $126.57 -0.24% 950K
|
Health Technology
|
| O: 0.36%
H: 0.8%
C: 0.75%
keytruda trial therapy cancer
Gainers vs Losers
| 66% | 34% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.78 52.14% 15M
|
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
TROO | $1.57 44.04% 2.8M
|
Manufacturing
RILY | $30.87 42.13% 7.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
RCAT | $1.52 26.67% 1.3M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.